A plain language summary of results from the TORCHLIGHT trial of toripalimab plus chemotherapy for metastatic or recurrent triple-negative breast cancerYuan Sheng, Tao Sun, Qingyuan Zhang et al.|Future Oncology|2024Cited by 1